Controlled release of peptide from biodegradable platforms for cardiovascular applications
Cenderitide, also known as CD-NP, is a designer peptide developed by Mayo Clinic for treating cardiovascular pathologies. CD-NP is synthesized by combining native mammalian c-type natriuretic peptide (CNP) and a C-terminus isolated from the dendroapis natriuretic peptide (DNP) of the venom of green...
Saved in:
| 主要作者: | |
|---|---|
| 其他作者: | |
| 格式: | Theses and Dissertations |
| 語言: | English |
| 出版: |
2013
|
| 主題: | |
| 在線閱讀: | https://hdl.handle.net/10356/55154 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
成為第一個發表評論!